SCINAI IMMUNOTHERAPEUTICS
LIVE

Serial Number

79387398

Owner

BiondVax Pharmaceuticals Ltd.

Attorney

Kevin D. McCarthy

Filing Date

Aug 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SCINAI IMMUNOTHERAPEUTICS Trademark

Serial Number: 79387398 • Registration: 7561660

SCINAI IMMUNOTHERAPEUTICS is a trademark filed by BiondVax Pharmaceuticals Ltd. on August 22, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BiondVax Pharmaceuticals Ltd. (5 trademarks)

Jerusalem BioPark Building, 2nd Floor,

Entity Type: 03

Scinai Immunotherapeutics Ltd. (4 trademarks)

Jerusalem BioPark Building, 2nd Floor,

Entity Type: 03

Trademark Details

Filing Date

August 22, 2023

Registration Date

November 12, 2024

Published for Opposition

August 27, 2024

Goods & Services

Pharmaceutical preparations comprising antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases; Pharmaceutical preparations comprising immunoglobulin moieties, fragments or derivatives thereof for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 27, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 10, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 3, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 13, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 13, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 12, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2024 NONP
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 23, 2024 ERSI
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2024 CNSA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 18, 2024 ADCH
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 9, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 9, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 9, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2024 TROA
REFUSAL PROCESSED BY IB
May 22, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2024 RFCS
REFUSAL PROCESSED BY MPU
May 1, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 11, 2024 REPR